Skip to main content
Erschienen in: Diabetologia 7/2009

01.07.2009 | Article

Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?

verfasst von: C. Sabanayagam, G. Liew, E. S. Tai, A. Shankar, S. C. Lim, T. Subramaniam, T. Y. Wong

Erschienen in: Diabetologia | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

This study was designed to determine whether the relationship of glycated haemoglobin to diabetic microvascular complications shows any natural thresholds that could be useful in diagnosing diabetes.

Methods

We examined a population-based sample of 3,190 Malay adults aged 40–80 years in Singapore. The microvascular outcomes of interest were: (1) any retinopathy, defined from fundus photographs; (2) mild retinopathy, defined as in (1); (3) moderate retinopathy, defined as in (1); (4) chronic kidney disease, defined from estimated glomerular filtration rate; (5) micro- or macroalbuminuria, defined from urinary albumin to creatinine ratio; and (6) peripheral neuropathy, defined from neurothesiometer or monofilament sensory testing.

Results

Increasing HbA1c was associated with all microvascular complications. The optimal cut-off points for detecting mild and moderate retinopathy were 6.6% (87.0% sensitivity, 77.1% specificity and area under the receiver operating characteristics [ROC] curve 0.899) and 7.0% (82.9% sensitivity, 82.3% specificity and area under ROC curve 0.904). The prevalences of mild and moderate retinopathy were <1% below the optimal cut-off points. For other complications, the association with HbA1c was linear without evidence of a distinct threshold. Although ROC analysis for these other complications also suggested optimal cut-off points between 6.6% and 7.0%, the sensitivity at these cut-off points was considerably lower than for mild and moderate retinopathy, ranging from 31.8% to 66.5%.

Conclusions/interpretation

Higher levels of HbA1c were associated with microvascular complications. Our data support use of an HbA1c cut-off point of between 6.6 and 7.0% in diagnosing diabetes. Cut-off points in this range were best for the identification of individuals with mild and moderate retinopathy. Any retinopathy, chronic kidney disease, albuminuria and peripheral neuropathy are less well detected at these cut-off points.
Literatur
1.
Zurück zum Zitat King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431PubMedCrossRef King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431PubMedCrossRef
2.
Zurück zum Zitat Anonymous (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20 Anonymous (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20
4.
Zurück zum Zitat Engelgau MM, Thompson TJ, Herman WH et al (1997) Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 20:785–791PubMedCrossRef Engelgau MM, Thompson TJ, Herman WH et al (1997) Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 20:785–791PubMedCrossRef
5.
Zurück zum Zitat McCance DR, Hanson RL, Charles MA et al (1994) Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323–1328PubMed McCance DR, Hanson RL, Charles MA et al (1994) Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323–1328PubMed
6.
Zurück zum Zitat Wong TY, Liew G, Tapp RJ et al (2008) Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 371:736–743PubMedCrossRef Wong TY, Liew G, Tapp RJ et al (2008) Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 371:736–743PubMedCrossRef
7.
Zurück zum Zitat American Diabetes Association (2007) Standards of medical care in diabetes–2007. Diabetes Care 30:S4–S41CrossRef American Diabetes Association (2007) Standards of medical care in diabetes–2007. Diabetes Care 30:S4–S41CrossRef
8.
Zurück zum Zitat Tapp RJ, Zimmet PZ, Harper CA et al (2006) Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract 73:315–321PubMedCrossRef Tapp RJ, Zimmet PZ, Harper CA et al (2006) Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract 73:315–321PubMedCrossRef
9.
Zurück zum Zitat Anonymous (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med 329:977–986CrossRef Anonymous (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med 329:977–986CrossRef
10.
Zurück zum Zitat Anonymous (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837–853CrossRef Anonymous (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837–853CrossRef
11.
Zurück zum Zitat Ito C, Maeda R, Ishida S, Sasaki H, Harada H (2000) Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 50:225–230PubMedCrossRef Ito C, Maeda R, Ishida S, Sasaki H, Harada H (2000) Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 50:225–230PubMedCrossRef
12.
Zurück zum Zitat Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB (2008) A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 93:2447–2453PubMedCrossRef Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB (2008) A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 93:2447–2453PubMedCrossRef
13.
Zurück zum Zitat Barr RG, Nathan DM, Meigs JB, Singer DE (2002) Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 137:263–272PubMed Barr RG, Nathan DM, Meigs JB, Singer DE (2002) Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 137:263–272PubMed
14.
Zurück zum Zitat Miyazaki M, Kubo M, Kiyohara Y et al (2004) Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 47:1411–1415PubMedCrossRef Miyazaki M, Kubo M, Kiyohara Y et al (2004) Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 47:1411–1415PubMedCrossRef
15.
Zurück zum Zitat Klein R, Klein BE, Moss SE (1996) Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124:90–96PubMed Klein R, Klein BE, Moss SE (1996) Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124:90–96PubMed
16.
Zurück zum Zitat Foong AW, Saw SM, Loo JL et al (2007) Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay Eye Study (SiMES). Ophthalmic Epidemiol 14:25–35PubMedCrossRef Foong AW, Saw SM, Loo JL et al (2007) Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay Eye Study (SiMES). Ophthalmic Epidemiol 14:25–35PubMedCrossRef
17.
Zurück zum Zitat Wong TY, Cheung N, Tay WT et al (2008) Prevalence and risk factors for diabetic retinopathy the Singapore Malay Eye Study. Ophthalmology 15:1869–1875CrossRef Wong TY, Cheung N, Tay WT et al (2008) Prevalence and risk factors for diabetic retinopathy the Singapore Malay Eye Study. Ophthalmology 15:1869–1875CrossRef
18.
Zurück zum Zitat Mitchell P, Smith W, Wang JJ, Attebo K (1998) Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 105:406–411PubMedCrossRef Mitchell P, Smith W, Wang JJ, Attebo K (1998) Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology 105:406–411PubMedCrossRef
19.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed
20.
Zurück zum Zitat Anonymous (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98:786–806 Anonymous (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98:786–806
21.
Zurück zum Zitat Anonymous (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–266CrossRef Anonymous (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–266CrossRef
22.
Zurück zum Zitat Shankar A, Leng C, Chia KS et al (2008) Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol Dial Transplant 23:1910–1918PubMedCrossRef Shankar A, Leng C, Chia KS et al (2008) Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol Dial Transplant 23:1910–1918PubMedCrossRef
23.
Zurück zum Zitat Young MJ, Every N, Boulton AJ (1993) A comparison of the neurothesiometer and biothesiometer for measuring vibration perception in diabetic patients. Diabetes Res Clin Pract 20:129–131PubMedCrossRef Young MJ, Every N, Boulton AJ (1993) A comparison of the neurothesiometer and biothesiometer for measuring vibration perception in diabetic patients. Diabetes Res Clin Pract 20:129–131PubMedCrossRef
24.
Zurück zum Zitat O'Neill J, McCann SM, Lagan KM (2006) Tuning fork (128 Hz) vs neurothesiometer: a comparison of methods of assessing vibration sensation in patients with diabetes mellitus. Int J Clin Pract 60:174–178PubMedCrossRef O'Neill J, McCann SM, Lagan KM (2006) Tuning fork (128 Hz) vs neurothesiometer: a comparison of methods of assessing vibration sensation in patients with diabetes mellitus. Int J Clin Pract 60:174–178PubMedCrossRef
25.
Zurück zum Zitat Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ (1991) Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 13:63–67PubMedCrossRef Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ (1991) Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 13:63–67PubMedCrossRef
26.
Zurück zum Zitat Ulm K (1991) A statistical method for assessing a threshold in epidemiological studies. Stat Med 10:341–349PubMedCrossRef Ulm K (1991) A statistical method for assessing a threshold in epidemiological studies. Stat Med 10:341–349PubMedCrossRef
27.
Zurück zum Zitat Nathan DM, Turgeon H, Regan S (2007) Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 50:2239–2244PubMedCrossRef Nathan DM, Turgeon H, Regan S (2007) Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 50:2239–2244PubMedCrossRef
28.
Zurück zum Zitat Saudek CD, Derr RL, Kalyani RR (2006) Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295:1688–1697PubMedCrossRef Saudek CD, Derr RL, Kalyani RR (2006) Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295:1688–1697PubMedCrossRef
29.
Zurück zum Zitat Bennett CM, Guo M, Dharmage SC (2007) HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 24:333–343PubMedCrossRef Bennett CM, Guo M, Dharmage SC (2007) HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 24:333–343PubMedCrossRef
30.
Zurück zum Zitat Peters AL, Davidson MB, Schriger DL, Hasselblad V (1996) A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis research group on the diagnosis of diabetes using glycated hemoglobin levels. JAMA 276:1246–1252PubMedCrossRef Peters AL, Davidson MB, Schriger DL, Hasselblad V (1996) A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis research group on the diagnosis of diabetes using glycated hemoglobin levels. JAMA 276:1246–1252PubMedCrossRef
31.
Zurück zum Zitat Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D (2005) Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 28:2436–2440PubMedCrossRef Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D (2005) Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 28:2436–2440PubMedCrossRef
32.
Zurück zum Zitat Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552–557PubMedCrossRef Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552–557PubMedCrossRef
33.
Zurück zum Zitat Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A (2008) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464–469PubMedCrossRef Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A (2008) Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464–469PubMedCrossRef
34.
Zurück zum Zitat Polydefkis M, Griffin JW, McArthur J (2003) New insights into diabetic polyneuropathy. JAMA 290:1371–1376PubMedCrossRef Polydefkis M, Griffin JW, McArthur J (2003) New insights into diabetic polyneuropathy. JAMA 290:1371–1376PubMedCrossRef
35.
Zurück zum Zitat Chao JR, Lai MY, Azen SP, Klein R, Varma R (2007) Retinopathy in persons without diabetes: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 48:4019–4025PubMedCrossRef Chao JR, Lai MY, Azen SP, Klein R, Varma R (2007) Retinopathy in persons without diabetes: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 48:4019–4025PubMedCrossRef
36.
Zurück zum Zitat Wong TY, Barr EL, Tapp RJ et al (2005) Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol 140:1157–1159PubMedCrossRef Wong TY, Barr EL, Tapp RJ et al (2005) Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol 140:1157–1159PubMedCrossRef
37.
Zurück zum Zitat Kawasaki R, Wang JJ, Wong TY, Kayama T, Yamashita H (2008) Impaired glucose tolerance, but not impaired fasting glucose, is associated with retinopathy in Japanese population: the Funagata study. Diabetes Obes Metab 10:514–515PubMedCrossRef Kawasaki R, Wang JJ, Wong TY, Kayama T, Yamashita H (2008) Impaired glucose tolerance, but not impaired fasting glucose, is associated with retinopathy in Japanese population: the Funagata study. Diabetes Obes Metab 10:514–515PubMedCrossRef
38.
Zurück zum Zitat Gerstein HC, Pogue J, Mann JF et al (2005) The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48:1749–1755PubMedCrossRef Gerstein HC, Pogue J, Mann JF et al (2005) The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 48:1749–1755PubMedCrossRef
39.
Zurück zum Zitat Haffner SM, Gonzales C, Valdez RA et al (1993) Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 36:1002–1006PubMedCrossRef Haffner SM, Gonzales C, Valdez RA et al (1993) Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 36:1002–1006PubMedCrossRef
40.
Zurück zum Zitat Yu T, Mitchell P, Berry G, Li W, Wang JJ (1998) Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 116:83–89PubMed Yu T, Mitchell P, Berry G, Li W, Wang JJ (1998) Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 116:83–89PubMed
41.
Zurück zum Zitat Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA (2004) A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 53:2883–2892PubMedCrossRef Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA (2004) A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 53:2883–2892PubMedCrossRef
42.
Zurück zum Zitat Anonymous (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563–2569CrossRef Anonymous (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563–2569CrossRef
43.
Zurück zum Zitat Anonymous (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159–2167CrossRef Anonymous (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159–2167CrossRef
44.
Zurück zum Zitat Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRef Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591PubMedCrossRef
45.
Zurück zum Zitat Moss SE, Meuer SM, Klein R, Hubbard LD, Brothers RJ, Klein BE (1989) Are seven standard photographic fields necessary for classification of diabetic retinopathy? Invest Ophthalmol Vis Sci 30:823–828PubMed Moss SE, Meuer SM, Klein R, Hubbard LD, Brothers RJ, Klein BE (1989) Are seven standard photographic fields necessary for classification of diabetic retinopathy? Invest Ophthalmol Vis Sci 30:823–828PubMed
46.
Zurück zum Zitat Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ (2004) Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 19:1175–1180PubMedCrossRef Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ (2004) Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 19:1175–1180PubMedCrossRef
47.
Zurück zum Zitat Rohlfing CL, Little RR, Wiedmeyer HM et al (2000) Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23:187–191PubMedCrossRef Rohlfing CL, Little RR, Wiedmeyer HM et al (2000) Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23:187–191PubMedCrossRef
48.
Zurück zum Zitat Anonymous (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44:968–983CrossRef Anonymous (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44:968–983CrossRef
49.
Zurück zum Zitat Ohkubo Y, Kishikawa H, Araki E et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117PubMedCrossRef Ohkubo Y, Kishikawa H, Araki E et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117PubMedCrossRef
50.
Zurück zum Zitat Warram JH, Scott LJ, Hanna LS et al (2000) Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes 49:94–100PubMedCrossRef Warram JH, Scott LJ, Hanna LS et al (2000) Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes 49:94–100PubMedCrossRef
Metadaten
Titel
Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?
verfasst von
C. Sabanayagam
G. Liew
E. S. Tai
A. Shankar
S. C. Lim
T. Subramaniam
T. Y. Wong
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 7/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1360-5

Weitere Artikel der Ausgabe 7/2009

Diabetologia 7/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.